MedTrace Logo

Sucrosomial Iron and Iron Sulphate to Blood Donors

NCT05678647 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2026-04-29

No results posted yet for this study

Summary

2 different oral iron supplementations after blood donation are compared.

Conditions

  • Blood Donation

Interventions

DRUG

Sucrosomial Iron

20 capsules of Sucrosomial Iron 30 mg is given after blood donation

DRUG

Iron Sulfate

20 tablets of oral iron sulphate (Duroferon®) 100 mg is given after blood donation

Sponsors & Collaborators

  • Uppsala University Hospital

    lead OTHER

Principal Investigators

  • Norbert Lubenow, PhD · Clinical Immunology and Transfusion Medicine Uppsala University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-01-31
Primary Completion
2026-03-01
Completion
2026-03-01

Countries

  • Sweden

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05678647 on ClinicalTrials.gov